Literature DB >> 22482704

Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections.

Nicolas Sémiramoth1, Chiara Di Meo, Fatima Zouhiri, Fatouma Saïd-Hassane, Sabrina Valetti, Roseline Gorges, Valérie Nicolas, Jacques H Poupaert, Sylvie Chollet-Martin, Didier Desmaële, Ruxandra Gref, Patrick Couvreur.   

Abstract

We describe here new nanoparticles based on the bioconjugation of penicillin G to squalene in order to overcome severe intracellular infections by pathogen bacteria whose mechanism of resistance arises from the poor intracellular diffusion of several antibiotics. Two different squalene-penicillin G conjugates were synthesized (pH-sensitive and pH-insensitive), and their self-assembly as nanoparticles was investigated through morphology and stability studies. These nanoparticles had a size of 140 ± 10 nm (polydispersity index of 0.1) and a negative charge, and they did not display any supramolecular organization. Furthermore, they were found stable in water and in different culture medium. The cellular uptake and localization of these fluorescently labeled nanoparticles were explored on the macrophage cell line J774 by flow cytometry and confocal microscopy analysis. The squalenoylated nanoparticles were found to be cell internalized through clathrin-dependent and -independent endocytic pathways. Moreover, they induced an improved intracellular antibacterial activity on the facultative intracellular pathogen S. aureus, compared with free penicillin G, despite the absence of co-localization between the bacteria and the nanoparticles in the cells. This study suggests that the bioconjugation of an antibiotic to a squalene template could be a valuable approach for overcoming the antibiotic resistance due to intracellular bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22482704     DOI: 10.1021/nn204928v

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  26 in total

Review 1.  Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.

Authors:  Ana V Cheng; William M Wuest
Journal:  ACS Infect Dis       Date:  2019-04-10       Impact factor: 5.084

Review 2.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

Review 3.  One-component nanomedicine.

Authors:  Hao Su; Jin Mo Koo; Honggang Cui
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

Review 4.  Nanoparticle-based local antimicrobial drug delivery.

Authors:  Weiwei Gao; Yijie Chen; Yue Zhang; Qiangzhe Zhang; Liangfang Zhang
Journal:  Adv Drug Deliv Rev       Date:  2017-09-20       Impact factor: 15.470

Review 5.  Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells.

Authors:  Xiaoyu Li; Charos Omonova Tuychi Qizi; Amari Mohamed Khamis; Can Zhang; Zhigui Su
Journal:  Pharm Res       Date:  2022-06-03       Impact factor: 4.200

Review 6.  Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance.

Authors:  Maria Hassan Kiani; Muhammad Imran; Abida Raza; Gul Shahnaz
Journal:  Daru       Date:  2020-03-19       Impact factor: 3.117

7.  Antibiotic-Derived Lipid Nanoparticles to Treat Intracellular Staphylococcus aureus.

Authors:  Chengxiang Zhang; Weiyu Zhao; Cong Bian; Xucheng Hou; Binbin Deng; David W McComb; Xiaofang Chen; Yizhou Dong
Journal:  ACS Appl Bio Mater       Date:  2019-02-14

Review 8.  Self-assembling prodrugs.

Authors:  Andrew G Cheetham; Rami W Chakroun; Wang Ma; Honggang Cui
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

Review 9.  Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections.

Authors:  Nor Fadhilah Kamaruzzaman; Sharon Kendall; Liam Good
Journal:  Br J Pharmacol       Date:  2016-12-07       Impact factor: 8.739

10.  Building Nanostructures with Drugs.

Authors:  Wang Ma; Andrew G Cheetham; Honggang Cui
Journal:  Nano Today       Date:  2016-02       Impact factor: 20.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.